- Home
- BBIO vs SAIA Comparison
BBIO vs SAIA Comparison
Compare BBIO & SAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- SAIA
- Stock Information
- Founded
- BBIO 2015
- SAIA 1924
- Country
- BBIO United States
- SAIA United States
- Employees
- BBIO N/A
- SAIA N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- SAIA Trucking Freight/Courier Services
- Sector
- BBIO Health Care
- SAIA Industrials
- Exchange
- BBIO Nasdaq
- SAIA Nasdaq
- Market Cap
- BBIO 8.0B
- SAIA 7.2B
- IPO Year
- BBIO 2019
- SAIA 2002
- Fundamental
- Price
- BBIO $42.78
- SAIA $287.01
- Analyst Decision
- BBIO Strong Buy
- SAIA Buy
- Analyst Count
- BBIO 14
- SAIA 18
- Target Price
- BBIO $58.85
- SAIA $371.28
- AVG Volume (30 Days)
- BBIO 3.3M
- SAIA 728.9K
- Earning Date
- BBIO 07-31-2025
- SAIA 07-25-2025
- Dividend Yield
- BBIO N/A
- SAIA N/A
- EPS Growth
- BBIO N/A
- SAIA N/A
- EPS
- BBIO N/A
- SAIA 11.99
- Revenue
- BBIO $127,415,000.00
- SAIA $3,241,874,000.00
- Revenue This Year
- BBIO $102.05
- SAIA $3.18
- Revenue Next Year
- BBIO $54.69
- SAIA $7.34
- P/E Ratio
- BBIO N/A
- SAIA $23.86
- Revenue Growth
- BBIO N/A
- SAIA 8.95
- 52 Week Low
- BBIO $21.72
- SAIA $229.12
- 52 Week High
- BBIO $45.48
- SAIA $624.55
- Technical
- Relative Strength Index (RSI)
- BBIO 62.54
- SAIA 54.36
- Support Level
- BBIO $39.65
- SAIA $267.14
- Resistance Level
- BBIO $45.48
- SAIA $279.00
- Average True Range (ATR)
- BBIO 1.56
- SAIA 9.03
- MACD
- BBIO 0.15
- SAIA 2.83
- Stochastic Oscillator
- BBIO 60.90
- SAIA 91.20
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About SAIA Saia Inc.
Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.